FEMY — Femasys Income Statement
0.000.00%
- $30.24m
- $33.10m
- $1.63m
Annual income statement for Femasys, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1.04 | 1.18 | 1.21 | 1.07 | 1.63 |
| Cost of Revenue | |||||
| Gross Profit | 0.731 | 0.809 | 0.764 | 0.692 | 1.08 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Total Operating Expenses | 7.97 | 9.52 | 12.8 | 15.6 | 19.4 |
| Operating Profit | -6.93 | -8.34 | -11.6 | -14.5 | -17.8 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -6.91 | -7.53 | -11.4 | -14.2 | -18.8 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -6.91 | -7.54 | -11.4 | -14.2 | -18.8 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -6.91 | -7.54 | -11.4 | -14.2 | -18.8 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -6.91 | -7.54 | -11.4 | -14.2 | -18.8 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.588 | -1.12 | -0.964 | -0.926 | -0.845 |
| Dividends per Share |